Presentation is loading. Please wait.

Presentation is loading. Please wait.

Characterization of oprD promoter elements.

Published byAri Budiono Modified over 5 years ago

Similar presentations

Presentation on theme: "Characterization of oprD promoter elements."— Presentation transcript:

1 Characterization of oprD promoter elements.
Characterization of oprD promoter elements. Transcription of oprD in P. aeruginosa PAO1 initiates with equal frequencies from two start sites, located 23 bases (SS1) and 71 bases (SS2) upstream of the structural gene (ATG translation start codon is highlighted in orange). The putative −10 and −35 promoter elements for SS1 are highlighted in red, and the putative −10 and −35 promoter elements for SS2 are highlighted in blue. Philip D. Lister et al. Clin. Microbiol. Rev. 2009; doi: /CMR

Download ppt "Characterization of oprD promoter elements."

Similar presentations

Scientific Notation. = 5.4 =3.47 Write the following in standard form A 1.8 X 10⁴ B 3.47 X 10⁷ C 4.3 X 10⁰ D 5.4 X 10⁻⁴ E 5 X 10⁻⁶ F (6 X 10⁴) (7 X 10⁵)

Scientific Notation. = 5.4 =3.47 Write the following in standard form A 1.8 X 10⁴ B 3.47 X 10⁷ C 4.3 X 10⁰ D 5.4 X 10⁻⁴ E 5 X 10⁻⁶ F (6 X 10⁴) (7 X 10⁵)
Rationale for generation of reporter fusions by Red-mediated recombination. Rationale for generation of reporter fusions by Red-mediated recombination.

Rationale for generation of reporter fusions by Red-mediated recombination. Rationale for generation of reporter fusions by Red-mediated recombination.
Current position of MALDI-TOF MS in the workflow of the clinical microbiology laboratory, including the current options for analysis of bacteria directly.

Current position of MALDI-TOF MS in the workflow of the clinical microbiology laboratory, including the current options for analysis of bacteria directly.
Overview of potential risk or protective factors influencing the horizontal or vertical transmission of Neospora caninum and the occurrence of exogenous.

Overview of potential risk or protective factors influencing the horizontal or vertical transmission of Neospora caninum and the occurrence of exogenous.
Proposed informatics pipeline for microbial genomic analysis in the clinical microbiology laboratory. Proposed informatics pipeline for microbial genomic.

Proposed informatics pipeline for microbial genomic analysis in the clinical microbiology laboratory. Proposed informatics pipeline for microbial genomic.
Itraconazole tissue and fluid concentrations in humans as multiples of the maximal or simultaneously measured concentration in plasma (μg/ml) after systemic.

Itraconazole tissue and fluid concentrations in humans as multiples of the maximal or simultaneously measured concentration in plasma (μg/ml) after systemic.
Voriconazole tissue and fluid concentrations in humans as multiples of the maximal or simultaneously measured concentration in plasma (μg/ml) after systemic.

Voriconazole tissue and fluid concentrations in humans as multiples of the maximal or simultaneously measured concentration in plasma (μg/ml) after systemic.
Functional range and environmental niches of the Pseudomonas genus, highlighting the broad distribution of the P. fluorescens species complex. Functional.

Functional range and environmental niches of the Pseudomonas genus, highlighting the broad distribution of the P. fluorescens species complex. Functional.
Time line of the discovery of the species belonging to the genus Staphylococcus. Time line of the discovery of the species belonging to the genus Staphylococcus.

Time line of the discovery of the species belonging to the genus Staphylococcus. Time line of the discovery of the species belonging to the genus Staphylococcus.
Timeline of major events in influenza vaccine development.

Timeline of major events in influenza vaccine development.
Mutational resistance to fluoroquinolones and carbapenems involving chromosomally encoded mechanisms expressed by P. aeruginosa. Mutational resistance.

Mutational resistance to fluoroquinolones and carbapenems involving chromosomally encoded mechanisms expressed by P. aeruginosa. Mutational resistance.
Frequency of lesions detected using CNS imaging (computed tomography [CT] and magnetic resonance imaging [MRI]) on patients with baylisascariasis (see.

Frequency of lesions detected using CNS imaging (computed tomography [CT] and magnetic resonance imaging [MRI]) on patients with baylisascariasis (see.
Schematic representation of the HAV genome organization, translation products, and regions used for amplification. Schematic representation of the HAV.

Schematic representation of the HAV genome organization, translation products, and regions used for amplification. Schematic representation of the HAV.
Schematic representation of signaling by high-risk human papillomavirus HPV E7. Schematic representation of signaling by high-risk human papillomavirus.

Schematic representation of signaling by high-risk human papillomavirus HPV E7. Schematic representation of signaling by high-risk human papillomavirus.
Phylogenetic tree of 38 Pseudomonas type strains, based on the V3-V5 region sequence of the 16S rRNA gene (V3 primer, positions 442 to 492; and V5 primer,

Phylogenetic tree of 38 Pseudomonas type strains, based on the V3-V5 region sequence of the 16S rRNA gene (V3 primer, positions 442 to 492; and V5 primer,
RND efflux operons in P. aeruginosa.

RND efflux operons in P. aeruginosa.
Columbia blood agar plate showing an isogenic S

Columbia blood agar plate showing an isogenic S
Characteristics of the new family of telomeric Cryptosporidium proteins, Cops-1 and Chos-1. Characteristics of the new family of telomeric Cryptosporidium.

Characteristics of the new family of telomeric Cryptosporidium proteins, Cops-1 and Chos-1. Characteristics of the new family of telomeric Cryptosporidium.
Approximate numbers of cases per 100,000 individuals caused by penicillin resistance for each year (left). Approximate numbers of cases per 100,000 individuals.

Approximate numbers of cases per 100,000 individuals caused by penicillin resistance for each year (left). Approximate numbers of cases per 100,000 individuals.
Schematic representation of signaling by MCV large T antigen (T-Ag) and small t antigen (t-Ag). Schematic representation of signaling by MCV large T antigen.

Schematic representation of signaling by MCV large T antigen (T-Ag) and small t antigen (t-Ag). Schematic representation of signaling by MCV large T antigen.

Similar presentations

Ads by Google